Analogous to Figure 2A, decreasing the dose frequency does not commensurately decrease the weight loss efficacy of tirzepatide
The drug is not on the FDA Drug Shortage list, which is what authorized compounded semaglutide and tirzepatide during the 2023-2025 shortages
This physiological response affects approximately 85% of individuals attempting weight loss
Some patients find that an evening dose works better with their schedule, which is acceptable as long as you maintain the same time each day and wait 30 minutes before eating
semaglutide: Dosage Both tirzepatide and semaglutide are once-weekly injections, with dosages gradually increasing over time
Hernndez-Daz has served as chair for the Drug Safety and Risk Management Advisory Committee of the US Food and Drug Administration, as member of the NICHD Pregnancy & Neonatology (PN) Study Section, and as member of the Teratogenic Information Services (TERIS) Advisory Board